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INTRODUCTION
The synthesis of a variety of symmetric and asymmetric 
hydroxyfulvenes was attempted via reaction of lithium 
cyclopentadienide with acyl halides or esters. The purification and 
analysis of the products via Hydrogen Nuclear Magnetic 
Resonance (NMR) will be presented. Further experimentation 
with hydroxy fulvenes will potentially form precursors to 
compounds structurally similar to the Non-Steroidal Anti-
Inflammatory Drug (NSAID) CELEBREX (celecoxib). A series of 
potential analogous precursors in the form of alpha-beta 
unsaturated ketones have been developed. The conversion of these 
precursors into pyridazine compounds will be attempted in the 
future. After oxidation of the pyrazoline compounds, they could 
potentially have biological activity by acting through 
CycloOxygense-2 (COX-2) in the same manner to CELEBREX.
ABSTRACT
The broader objective of this research was to produce viable, or 
better, analogs for the prescription drug CELEBREX. 
CELEBREX is in the NSAID class of medications. NSAIDs are 
used to inhibit COX-2 (CycloOXygenase-2), which is a promoter 
of inflammation. CELEBREX is a unique compound as it does not 
inhibit COX-1 as other NSAIDs do. Other NSAIDs prevent the 
activity of COX-1, which ultimately prevents the stomach from 
producing enough of a mucus coating to protect it from its 
digestive acids; this can lead to ulcers in long term use. Celecoxib 
is selective for COX-2 due to sterics. Celecoxib’s relatively large 
structure fits into the pocket in the channel for COX-2. COX-1 
does not have this channel, therefore, celecoxib cannot fit. This is 
due to the two enzymes being isoforms, which means that the 
channels share the same chemical structure, but differ in spatial 
orientation. Figures 1 and 2 below depict reaction schemes for the 
generation of Cyclopentadienide from Dicyclopentadiene and 
generic acylation and formation of hydroxyfulvene product.
Generation of Lithium Cyclopentadienide 
Combined 0.569 mL cyclopentadiene, 2.78 mL of butyl-lithium, 
and 50 mL diethyl ether with stir bar into a 100 mL Schlenk flask 
under argon. The reaction was stirred while in an ice bath for a 
few minutes as the butyl-lithium was added via syringe needle. 
The resulting mixture was stirred until reagents were added.
Generation of Substituted Hydroxyfulvenes
Added 3 mmol equivalents of 2 reagents (such as m-toluoyl
chloride and 4-fluorobenzoyl chloride), and ~8-9 mL ether to 25 
mL round bottom flask. The mixture was added to 2 mmol 
equivalents of lithium cyclopentadienide in the reaction flask from 
previous generation. After warming to room temperature, the 
mixture stirred overnight. An acid workup was performed using 
HCl, excess water was removed using a desiccant, and leftover 
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There has been modest success with these procedures in regard to 
H-NMR and Thin-Layer Chromatography (TLC). When analyzing 
the hydroxyfulvene compounds with Nuclear Magnetic Imaging 
(H-NMR), a reaction was deemed successful at minimum if one 
robust peak was present between 18 and 20 ppm, and if the peaks 
for an aromatic group and starting compound exclusive peaks had 
appeared (between 7 and 9 ppm). Several compounds were 
deemed to have potential, but required further investigation. This 
was achieved through separation via TLC using silica plates and 
varying mixtures of mobile phases, although it was found that a 
mixture of pentane and diethyl ether worked best. To further 
separate compounds, column chromatography was used, however 
there was little separation with this method versus the TLC. 
PROPOSED REACTION SCHEME
Reaction mechanism for the generation of lithium cyclopentadienide via Retro-Diels–Alder
reaction (Figure 1). Subsequently reacted with varying combinations of acyl halide reagents 
in a 3:1:1 ratio, or 3:2 if symmetrical hydroxyfulvene formation (Figure 2).
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Figure 1. Formation of Cyclopentadienide.
Figure 2. Formation of generic hydroxyfulvene product.
Early trials prepared using solid lithium cyclopentadienide were shown 
to have much smaller yields as the solid form readily reacts in normal 
atmosphere, thus producing an unreactive byproduct. This is evident by 
the presence of carboxylic acid derivatives of the acyl halide reagents 
used. Lithium Cyclopentadienide reactions, from distillation of 
dicyclopentadiene and butyl lithium, proved much more reactive and 
trials using this starting material produced mixtures of the three 
possible hydroxyfulvene derivatives shown in H1-NMR analysis.
